Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Sep 22;16(9):1498. doi: 10.3390/v16091498

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Figure A12 — Funnel plots for findings included in meta-analysis: (a) seroprevalence of IgM for Oropouche Virus (OROV) among individuals with any sign/symptom of arbovirus infection; (b) seroprevalence of OROV IgG/IgM among individuals with any sign/symptom of arbovirus infection; (c) prevalence of OROV isolates (viral particles and/or viral RNA) among individuals with any sign/symptom of arbovirus infection; (d) seroprevalence of OROV IgG/IgM among individuals with any sign/symptom of arbovirus infection; (e) seroprevalence of OROV IgG among individuals with any sign/symptom of arbovirus infection; (f) prevalence of OROV isolates (viral particles and/or viral RNA) within cerebrospinal fluid of individuals with any sign/symptom of arbovirus infection [10,11,12,14,16,17,20,23,24,25,33,35,40,41,42,48,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91].

Figure A12 — Funnel plots for findings included in meta-analysis: (a) seroprevalence of IgM for Oropouche Virus (OROV) among individuals with any sign/symptom of arbovirus infection; (b) seroprevalence of OROV IgG/IgM among individuals with any sign/symptom of arbovirus infection; (c) prevalence of OROV isolates (viral particles and/or viral RNA) among individuals with any sign/symptom of arbovirus infection; (d) seroprevalence of OROV IgG/IgM among individuals with any sign/symptom of arbovirus infection; (e) seroprevalence of OROV IgG among individuals with any sign/symptom of arbovirus infection; (f) prevalence of OROV isolates (viral particles and/or viral RNA) within cerebrospinal fluid of individuals with any sign/symptom of arbovirus infection [10,11,12,14,16,17,20,23,24,25,33,35,40,41,42,48,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91].